Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study.

Liver cancer（2022）

引用 10|浏览10

暂无评分

摘要

Our study confirms in a large and global population of patients with advanced HCC, not candidates for locoregional treatment the OS reported in the registration study and a high response rate with lenvatinib.

查看译文

关键词

ALBI,Hepatocellular carcinoma,Lenvatinib,Neutrophils to lymphocyte ratio,Nonalcoholic fatty liver disease,Nonalcoholic steatohepatitis,Outcome,Second line,Tyrosine kinase inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要